Published in J Clin Invest on September 01, 1973
Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". J Clin Invest (1975) 1.49
Thyroid hormone stimulates de novo growth hormone synthesis in cultured GH1 cells: evidence for the accumulation of a rate limiting RNA species in the induction process. Proc Natl Acad Sci U S A (1976) 1.28
Metabolic clearance and production rates of prolactin in man. J Clin Invest (1979) 0.91
Neuroendocrine causes of amenorrhea--an update. J Clin Endocrinol Metab (2015) 0.79
The effect of dexamethasone on TSH and prolactin secretion after TRH stimulation. Can Med Assoc J (1974) 0.77
Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature. Postgrad Med J (1984) 0.75
The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients. Eur Arch Psychiatry Clin Neurosci (2005) 0.75
DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING. J Clin Endocrinol Metab (1964) 3.19
Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem Biophys Res Commun (1971) 2.07
Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab (1971) 1.96
Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab (1972) 1.82
Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest (1972) 1.77
Triiodothyronine radioimmunoassay. J Clin Invest (1972) 1.54
A mixed heterologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab (1972) 1.31
Prolactin release after injection of thyrotrophin-releasing hormone in man. Lancet (1972) 1.23
Human prolactin: isolation and some properties. Biochem Biophys Res Commun (1971) 1.17
Prolactin stimulation by thyrotropin-releasing hormone in a patient with isolated thyrotropin deficiency. N Engl J Med (1972) 1.11
Prolactin response to thyrotropin releasing hormone in normal subjects. J Clin Endocrinol Metab (1973) 1.10
Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone. J Clin Invest (1972) 1.08
Thyrotropin releasing factor (TRF) effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopituitary dwarfism: further evidence for hypophysiotropic hormone deficiencies. J Clin Endocrinol Metab (1972) 0.90
Disclosure of authors' conflicts of interest: a follow-up. N Engl J Med (2000) 3.16
Growth hormone secretion during sleep. J Clin Invest (1968) 2.90
A failed assay opened a new door in growth hormone research. Endocrinology (1992) 2.69
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab (2000) 2.68
Somatomedin: proposed designation for sulphation factor. Nature (1972) 2.63
Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res (1967) 2.48
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ (1990) 2.24
Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab (1995) 2.20
Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab (2000) 1.99
A factor analysis of the Klein sexual orientation grid in two disparate samples. Arch Sex Behav (1993) 1.98
Treatment of primary hyperparathyroidism. N Engl J Med (1999) 1.97
Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab (1980) 1.96
Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab (1971) 1.96
Maternal hypothyroidism and fetal development. N Engl J Med (1999) 1.92
Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab (1972) 1.82
Digital topological analysis of in vivo magnetic resonance microimages of trabecular bone reveals structural implications of osteoporosis. J Bone Miner Res (2001) 1.80
Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest (1972) 1.77
Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med (1980) 1.73
Recognition of gonadotroph adenomas in women. N Engl J Med (1991) 1.70
Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav (1978) 1.69
Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation. Hum Mol Genet (1993) 1.67
The effect of glucocorticoids on thyrotropin secretion. J Clin Invest (1969) 1.61
Iodothyronine metabolism in rat liver homogenates. J Clin Invest (1978) 1.56
Triiodothyronine radioimmunoassay. J Clin Invest (1972) 1.54
Binding of microtubules to pituitary secretory granules and secretory granule membranes. J Cell Biol (1977) 1.46
Neuropsychiatric side effects related to treatment with felbamate. J Neuropsychiatry Clin Neurosci (1996) 1.46
A cohort mortality study of two California refinery and petrochemical plants. J Occup Med (1993) 1.45
Thyrotropin-releasing hormone: regional distribution in rat brain. Science (1974) 1.45
The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J Clin Endocrinol Metab (1967) 1.45
Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab (1971) 1.43
Levodopa suppression of prolactin in nonpuerperal galactorrhea. N Engl J Med (1971) 1.41
Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man. N Engl J Med (1971) 1.40
The role of androgens in women. J Clin Endocrinol Metab (2001) 1.40
The need for more vitamin D. N Engl J Med (1998) 1.40
Hyperthyroidism and excessive thyrotropin secretion. N Engl J Med (1972) 1.37
Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications. Ann Intern Med (1977) 1.33
A mixed heterologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab (1972) 1.31
Ultrastructural, histologic and hormonal characterization of a prolactin-rich human pituitary tumor. J Clin Endocrinol Metab (1969) 1.28
Viral perturbation of endocrine function: disordered cell function leads to disturbed homeostasis and disease. Nature (1984) 1.27
Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab (1978) 1.27
Dihydropyridine actions on calcium currents of frog sympathetic neurons. J Neurosci (1990) 1.26
The regulation of growth by endocrines. Annu Rev Physiol (1975) 1.26
Kallmann syndrome: MR evaluation of olfactory system. AJNR Am J Neuroradiol (1993) 1.24
Inappropriate antidiuresis and carcinoma of the lung: detection of arginine vasopressin in tumor extracts by immunoassay. J Clin Endocrinol Metab (1966) 1.23
Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology (2000) 1.23
Thyrotropin response to thyrotropin releasing hormone in normal females over forty. J Clin Endocrinol Metab (1972) 1.23
Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry (1994) 1.23
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol (2001) 1.20
Thyrotropin-releasing hormone in specific nuclei of rat brain. Science (1974) 1.19
Endocrine, cardiovascular, and psychological correlated of olfactory sensitivity changes during the human menstrual cycle. J Comp Physiol Psychol (1981) 1.19
Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest (1975) 1.19
Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J Clin Endocrinol Metab (1967) 1.19
Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study. Arch Gen Psychiatry (1980) 1.18
Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J Clin Endocrinol Metab (1968) 1.17
Iodothyronine metabolism in liver and kidney homogenates from hyperthyroid and hypothyroid rats. Endocrinology (1978) 1.16
A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient. Nat Genet (1993) 1.15
Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet (1995) 1.15
Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly. J Lab Clin Med (1965) 1.15
Regulation of growth hormone secretion in acromegaly. J Clin Endocrinol Metab (1969) 1.15
Isolation and partial sequence analysis of rat basic somatomedin. Endocrinology (1982) 1.12
Serum thyrotropin and thyroxine concentrations in patients recieving lithium carbonate. J Clin Endocrinol Metab (1973) 1.12
Immunochemical studies with lysine vasopressin. Endocrinology (1966) 1.12
Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin. J Clin Endocrinol Metab (1975) 1.11
Radioimmunoassayable growth hormone in the rat pituitary gland: effects of age, sex and hormonal state. Endocrinology (1967) 1.10
Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci U S A (1987) 1.10
Prolactin response to thyrotropin releasing hormone in normal subjects. J Clin Endocrinol Metab (1973) 1.10
Human placental lactogen: studies of its acute metabolic effects and disposition in normal man. J Clin Invest (1967) 1.09
Estimation of the secretion rate of thyrotropin in man. J Clin Invest (1967) 1.09
Testicular function after orchiopexy for unilaterally undescended testis. N Engl J Med (1976) 1.08
Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med (1979) 1.08
Attempts to augment thyrotropin secretion. Effects of methimazole, methimazole-iodide, vasopressin, and glucagon. Metabolism (1970) 1.08
Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. J Clin Endocrinol Metab (1982) 1.08
Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone. J Clin Invest (1972) 1.08
Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med (1992) 1.07
Disturbances of pituitary function in central nervous system disease. Med Clin North Am (1968) 1.07
Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor. J Clin Endocrinol Metab (1981) 1.07
Sulfation factor regulation of skeletal growth. A stable mechanism dependent on intermittent growth hormone secretion. Am J Med (1971) 1.06
Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun (1999) 1.05
Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J Clin Endocrinol Metab (1974) 1.05
Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab (1991) 1.05
Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J Clin Endocrinol Metab (1981) 1.05
Gonadotroph cell adenomas of the pituitary. Endocr Rev (1985) 1.04
Radioimmunologic measurement of human placental lactogen in plasma by a double antibody method during normal and diabetic pregnancies. J Clin Endocrinol Metab (1965) 1.04
Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) (2001) 1.04
A pill for impotence. N Engl J Med (1998) 1.04